|

NN3201 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Novelty Nobility, Inc.1

Indications

  • Chromophobe Renal Cell Carcinoma1
  • Clear Cell Renal Cell Carcinoma1
  • Adenoid Cystic Carcinoma1
  • Gastrointestinal Stromal Tumors1
  • Uveal Melanoma1

Ann Arbor, Michigan1 trial

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

University of Michigan Hospitals

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.